COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?

Fekkar, Arnaud; Neofytos, Dionysios; Nguyen, Minh-Hong; Clancy, Cornelius J; Kontoyiannis, Dimitrios P; Lamoth, Frederic

doi:10.1016/j.cmi.2021.06.025

Scientific article

Letter

English

COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?

ContributorsFekkar, Arnaud; Neofytos, Dionysios; Nguyen, Minh-Hong; Clancy, Cornelius J; Kontoyiannis, Dimitrios P; Lamoth, Frederic

Published inClinical microbiology and infection, vol. 27, no. 9, p. 1376-1378

Publication date2021-09

First online date2021-06-27

Keywords

COVID-19 / complications
Coinfection / diagnosis
Coinfection / epidemiology
Humans
Invasive Pulmonary Aspergillosis / diagnosis
Invasive Pulmonary Aspergillosis / epidemiology
Invasive Pulmonary Aspergillosis / virology
SARS-CoV-2

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Citation (ISO format)

FEKKAR, Arnaud et al. COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it? In: Clinical microbiology and infection, 2021, vol. 27, n° 9, p. 1376–1378. doi: 10.1016/j.cmi.2021.06.025

Article (Published version)

OA OTHER

Identifiers

PID : unige:162425
DOI : 10.1016/j.cmi.2021.06.025
PMID : 34192575
PMCID : PMC8275029

Journal ISSN1198-743X

156views

65downloads

Creation23/03/2022 13:15:00

First validation23/03/2022 13:15:00

Update time16/03/2023 08:05:22

Status update16/03/2023 08:05:21

Last indexation01/11/2024 03:21:13

Archive ouverte UNIGE

COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?

Technical informations